Citations

Mayo Clinic

Showing 10 of 108602 citations.

Safety and Performance of a Novel Implantable Sensor in the Inferior Vena Cava Under Acute and Chronic Intravascular Volume Modulation
Sheridan, William S., Wetterling, Friedrich , Fudim, Marat , Damman, Kevin , Gray, Alastair , Gaines, P.A. , Poloczek, Martin, Madden, Stephen F. , Buxó, Teresa , Gaul, Robert , Corcoran, Louise, Sweeney, Fiachra, Testani, Jeffrey M. , Borlaug, Barry A. , Tucker, James, Burkhoff, Daniel

European Journal of Heart Failure | March 9, 2023 | Volume: 25 | Issue: 5 | Pages: 754-763

10.1002/ejhf.2822 | PMID 36891760 Get It

ABSTRACT Aims The management of congestion is one of the key treatment targets in heart failure. Assessing congestion is, however, difficult. The purpose of this study was to investigate the safety and dynamic response of a novel, passive, inferior vena cava (IVC) sensor in a chronic ovine model. Methods and results A total of 20 sheep divided into three groups were studied in acute and chronic in vivo settings. Group I and Group II included 14 sheep in total with 12 sheep receiving the sensor and two sheep receiving a control device (IVC filter). Group III included an additional six animals for studying responses to volume challenges via infusion of blood and saline solutions. Deployment was 100% successful with all devices implanted; performing as expected with no device-related complications and signals were received at all observations. At similar volume states no significant differences in IVC area normalized to absolute area range were measured (55 ± 17% on day 0 and 62 ± 12% on day 120, p = 0.51). Chronically, the sensors were completely integrated with a thin, reendothelialized neointima with no loss of sensitivity to infused volume. Normalized IVC area changed significantly from 25 ± 17% to 43 ± 11% (p = 0.007) with 300 ml infused. In contrast, right atrial pressure required 1200 ml of infused volume prior to a statistically significant change from 3.1 ± 2.6 mmHg to 7.5 ± 2.0 mmHg (p = 0.02). Conclusion In conclusion, IVC area can be measured remotely in real-time using a safe, accurate, wireless, and chronic implantable sensor promising to detect congestion with higher sensitivity than filling pressures.
T Cell Responses Correlate with Self-Reported Disease Severity and Neutralizing Antibody Responses Predict Protection against SARS-CoV-2 Breakthrough Infection
Zhao, Zhen , Kumánovics, Attila , Love, Tanzy , Melanson, Stacy E.F. , Wu, Alan H.B. , Wiencek, Joesph R , Apple, Fred S. , Ondracek, Caitlin R. , Koch, David D., Christenson, Robert H. , Zhang, Yan Victoria, Wiencek, Joesph , Ondracek, Caitlin R , Meng, Qing H.

Viruses | March 9, 2023 | Volume: 15 | Issue: 3 | Pages: 709

10.3390/v15030709 | PMID 36992418 Get It

Objectives: The objective of this prospective study was to investigate the role of adaptive immunity in response to SARS-CoV-2 vaccines. Design and Methods: A cohort of 677 vaccinated individuals participated in a comprehensive survey of their vaccination status and associated side effects, and donated blood to evaluate their adaptive immune responses by neutralizing antibody (NAb) and T cell responses. The cohort then completed a follow-up survey to investigate the occurrence of breakthrough infections. Results: NAb levels were the highest in participants vaccinated with Moderna, followed by Pfizer and Johnson & Johnson. NAb levels decreased with time after vaccination with Pfizer and Johnson & Johnson. T cell responses showed no significant difference among the different vaccines and remained stable up to 10 months after the study period for all vaccine types. In multivariate analyses, NAb responses (<95 U/mL) predicted breakthrough infection, whereas previous infection, the type of vaccine, and T cell responses did not. T cell responses to viral epitopes (<0.120 IU/mL) showed a significant association with the self-reported severity of COVID-19 disease. Conclusion: This study provides evidence that NAb responses to SARS-CoV-2 vaccination correlate with protection against infection, whereas the T cell memory responses may contribute to protection against severe disease but not against infection.
Direct anterior approach associated with lower dislocation risk after primary total hip arthroplasty in patients with prior lumbar spine fusion
Sebro, Ronnie , Baranek, Morgan, Goulding, Krista , Wilke, Benjamin K. , Iturregui, Jose M. , Stanborough, Rupert O. , Goulding, Krista A., Ledford, Cameron K. , Wilke, B K , Garner, Hillary W.

HIP International | March 9, 2023 | Volume: 33 | Issue: 6 | Pages: 1043-1048

10.1177/11207000231155797 | PMID 36891586 Get It

Background: While there has been much interest in the increased dislocation rate in total hip arthroplasty (THA) patients with a lumbar spine fusion (LSF), there is minimal literature comparing the risk based on surgical approach. The purpose of this study was to determine if a direct anterior (DA) approach was protective against dislocation when compared to the anterolateral and posterior approaches in this high-risk patient population. Methods: A retrospective review was performed of 6554 THAs performed at our institution from January 2011 to May 2021. 294 (4.5%) patients had a prior LSF and were included in the analysis. The surgical approach, timing of LSF in relation to THA, vertebral levels fused, timing of THA dislocation, and the need for revision surgery were recorded for statistical analysis. Results: In total, 39.7.3% of patients underwent a DA approach (n = 117), 25.9% underwent an anterolateral approach ( n = 76), and 34.3% underwent a posterior approach ( n = 101). There was no difference in number of vertebral levels fused between groups (mean 2.5, all p > 0.05). There was a total of 13 (4.4%) THA dislocation events, with an average time from surgery to dislocation of 5.6 months (0.3–30.5 months). There were fewer dislocations in the DA cohort (0.9%) in comparison to both the anterolateral (6.6%, p = 0.036) and posterior groups (6.9%, p = 0.026). Conclusions: The DA approach demonstrated a significantly lower THA dislocation rate compared to both the anterolateral and posterior approaches in patients with a concomitant LSF.
Performing Automatic Identification and Staging of Urothelial Carcinoma in Bladder Cancer Patients Using a Hybrid Deep-Machine Learning Approach
Sarkar, Suryadipto , Min, Kong, Ikram, Waleed, Tatton, Ryan W. , Silva, Alvin C. , Bryce, Alan H. , Moore, Cassandra, Ho, Thai H. , Sonpavde, Guru , Abdul-Muhsin, Haidar , Singh, Parminder , Bryce, Alan H , Sonpavde, Guru , Ho, Thai , Singh, Parminder , Min, Kong, Riaz, Irbaz Bin , Moore, Cassandra, Singh, Parminder Pal , Wu, Teresa

Cancers | March 9, 2023 | Volume: 15 | Issue: 6 | Pages: 1673

10.3390/cancers15061673 | PMID 36980557 Get It

Accurate clinical staging of bladder cancer aids in optimizing the process of clinical decision-making, thereby tailoring the effective treatment and management of patients. While several radiomics approaches have been developed to facilitate the process of clinical diagnosis and staging of bladder cancer using grayscale computed tomography (CT) scans, the performances of these models have been low, with little validation and no clear consensus on specific imaging signatures. We propose a hybrid framework comprising pre-trained deep neural networks for feature extraction, in combination with statistical machine learning techniques for classification, which is capable of performing the following classification tasks: (1) bladder cancer tissue vs. normal tissue, (2) muscle-invasive bladder cancer (MIBC) vs. non-muscle-invasive bladder cancer (NMIBC), and (3) post-treatment changes (PTC) vs. MIBC.
Does Notching Along the Nasal Velar Surface During Nasopharyngoscopy Predict Discontinuity of the Underlying Levator Veli Palatini Muscle?
Perry, Jamie L. , Kinter, Sara , Chee-Williams, Jessica L. , Snodgrass, Taylor D. , Sitzman, Thomas J. , Sitzman, Thomas J , Chee-Williams, Jessica L , Snodgrass, Taylor , Perry, Jamie L

The Cleft Palate Craniofacial Journal | March 9, 2023 | Volume: 61 | Issue: 7 | Pages: 1096-1103

10.1177/10556656231161991 | PMID 36890699 Get It

To determine the sensitivity and specificity of velar notching seen on nasopharyngoscopy for levator veli palatini (LVP) muscle discontinuity and anterior positioning. Nasopharyngoscopy and MRI of the velopharynx were performed on patients with VPI as part of their routine clinical care. Two speech-language pathologists independently evaluated nasopharyngoscopy studies for the presence or absence of velar notching. MRI was used to evaluate LVP muscle cohesiveness and position relative to the posterior hard palate. To determine the accuracy of velar notching for detecting LVP muscle discontinuity, sensitivity, specificity, and positive predictive value (PPV) were calculated. A craniofacial clinic at a large metropolitan hospital. Participants Thirty-seven patients who presented with hypernasality and/or audible nasal emission on speech evaluation and completed nasopharyngoscopy and velopharyngeal MRI study as part of their preoperative clinical evaluation. Among patients with partial or total LVP dehiscence on MRI, presence of a notch accurately identified discontinuity in the LVP 43% (95% CI 22-66%) of the time. In contrast, the absence of a notch accurately indicated LVP continuity 81% (95% CI 54-96%) of the time. The PPV for the presence of notching to identify a discontinuous LVP was 78% (95% CI 49-91%). The distance from the posterior edge of the hard palate to the LVP, known as effective velar length, was similar in patients with and without notching (median 9.8 mm vs 10.5 mm, P = 1.00). The observation of a velar notch on nasopharyngoscopy is not an accurate predictor of LVP muscle dehiscence or anterior positioning.
Surgical Education: Disparities in Education May Impact the Quality and Likelihood of Completion of Training
Ofshteyn, Asya , Steinhagen, Emily

Clinics in Colon and Rectal Surgery | March 8, 2023 | Volume: 36 | Issue: 05 | Pages: 315-320

10.1055/s-0043-1763519 | PMID 37564350 Get It

AbstractFemale surgical trainees experience bias that begins at the preclinical stages of medical school, extending into their surgery clerkships, and then into their residency training. There are important implications in terms of training opportunities and career advancement, mentorship, sponsorship, and ultimately burnout. Childbearing and lactation also impact the experiences and perceptions of female trainees who have children. There are limited interventions that have improved the experience of women in surgical training. Mentorship appears to play an important role in ameliorating some of the negative consequences of the training environment and improving outcomes for women surgeons.
The Mortality Benefit of Milrinone as a Continuous Outpatient Intravenous Inotrope Therapy in Advanced Heart Failure: A Systemic Review and Meta-Analysis
Rio‐Pertuz, Gaspar Del , Benjanuwattra, Juthipong , Phinyo, Phichayut , Leelaviwat, Natnicha , Mekraksakit, Poemlarp , Nair, Nandini, Del Rio-Pertuz, Gaspar , Mekraksakit, Poemlarp

International Journal of Heart Failure | March 8, 2023 | Volume: 5 | Issue: 2 | Pages: 106

10.36628/ijhf.2022.0034 | PMID 37180559 Get It

Characterization of Stone Events in Patients With Type 3 Primary Hyperoxaluria
Arnous, Muhammad G. , Vaughan, Lisa E. , Mehta, Ramila A. , Schulte, Phillip J. , Lieske, John C. , Milliner, Dawn S. , Vaughan, Lisa, Lieske, John C

Journal of Urology | March 8, 2023 | Volume: 209 | Issue: 6 | Pages: 1141-1150

10.1097/ju.0000000000003400 | PMID 36888927 Get It

Future landscape for the management of membranous nephropathy
Caravaca‐Fontán, Fernando , Yandián, Federico , Fervenza, Fernando C. , Fervenza, Fernando C , Caravaca-Fontán, Fernando

Clinical Kidney Journal | March 8, 2023 | Volume: 16 | Issue: 8 | Pages: 1228-1238

10.1093/ckj/sfad041 | PMID 37529655 Get It

ABSTRACT Among all glomerular diseases, membranous nephropathy (MN) is perhaps the one in which major progress has been made in recent decades, in both the understanding of the pathogenesis and treatment. Despite the overall significant response rates to these therapies—particularly rituximab and cyclical regimen based on corticosteroids and cyclophosphamide—cumulative experience over the years has shown, however, that 20%–30% of cases may confront resistant disease. Thus, these unmet challenges in the treatment of resistant forms of MN require newer approaches. Several emerging new agents—developed primarily for the treatment of hematological malignancies or rheumatoid diseases—are currently being evaluated in MN. Herein we conducted a narrative review on future therapeutic strategies in the disease. Among the different novel therapies, newer anti-CD20 agents (e.g. obinutuzumab), anti-CD38 (e.g. daratumumab, felzartamab), immunoadsorption or anti-complement therapies (e.g. iptacopan) have gained special attention. In addition, several technologies and innovations developed primarily for cancer (e.g. chimeric antigen receptor T-cell therapy, sweeping antibodies) seem particularly promising. In summary, the future therapeutic landscape in MN seems encouraging and will definitely move the management of this disease towards a more precision-based approach.
Tissue Inhibitor Metalloproteinase-2 and Insulin-Like Growth Factor Binding Protein-7 Kinetics Following Exposure to High-Dose Methotrexate
Barreto, Jason N. , Frazee, Erin N. , Mara, Kristin C. , Rule, Andrew D. , Lieske, John C. , Giesen, Callen D., Thompson, Carrie A. , Leung, Nelson , Kashani, Kianoush , Frazee, Erin N , Kashani, Kianoush B , Leung, Nelson , Rule, Andrew D , Lieske, John C , Mara, Kristin C , Witzig, Thomas E.

Kidney360 | March 8, 2023 | Volume: 4 | Issue: 5 | Pages: 673-679

10.34067/kid.0000000000000099 | PMID 36888987 Get It

Key Points Urinary TIMP2×IGFBP7 (uTIMP2×IGFBP7) concentrations experienced a rapid and sustained decline after high-dose methotrexate (MTX) exposure. uTIMP2×IGFBP7 kinetics and concentrations after high-dose MTX exposure demonstrated no utility in predicting AKI.